US · Healthcare · Medical Devices
EPS came in at 2.09 against a street estimate of 1.86 — a beat of 12.4%.
Analysts rate Zimmer Biomet Holdings Inc a hold (11 buy, 16 hold, 2 sell out of 29) with an average price target of $99.38.
| Fund | Stake |
|---|---|
| Dodge & Cox | 12.17% |
| BlackRock Inc | 7.93% |
| Harris Associates L.P. | 6.70% |
| Vanguard Capital Management, LLC | 6.61% |
| Capital Research & Mgmt Co - Division 3 | 4.71% |
| State Street Corp | 4.56% |
| Vanguard Portfolio Management, LLC | 4.47% |
| T. Rowe Price Associates, Inc. | 4.13% |
| Document | Date |
|---|---|
| Material agreement · Q2 2026 | 2026-06-29 |
| Shareholder vote results · Q2 2026 | 2026-05-27 |
| Reg FD disclosure · Q2 2026 | 2026-05-12 |
| Quarterly report · Q1 2026 | 2026-05-01 |
| Board / officer change · Q2 2026 | 2026-04-28 |
| Proxy statement · Q2 2026 | 2026-04-01 |
| Annual report FY2025 | 2026-02-20 |
| Quarterly report · Q3 2025 | 2025-11-05 |
Readable in the app.
| Announcement | Date |
|---|---|
| Increases share repurchase expectations to $1 billion by year end Zimmer Biomet announced it is increasing its share repurchase program by $250 million, now expecting to buy back up to $1 billion of its own stock during fiscal year 2026. This increase come | 2026-05-12 |
| Q1 2026 results; raises full-year adjusted EPS and free cash flow guidance Zimmer Biomet, a medical device company, reported strong first quarter 2026 results. Net sales reached $2.087 billion, up 9.3% year-over-year (6.8% excluding currency effects, 2.9% organic g | 2026-04-28 |
| Board approves new $1.5 billion stock repurchase authorization Zimmer Biomet, a medical device company, reported 2025 results showing mixed performance. Revenue grew 7.2% to $8.232 billion, though organic growth was modest at 3.9%. Fourth quarter sales | 2026-02-10 |
| Announced definitive agreement to acquire Monogram Technologies Zimmer Biomet reported strong Q2 2025 results with net sales of $2.077 billion, up 7.0% year-over-year (5.4% in constant currency, 2.8% organically). Adjusted earnings per share increased 3. | 2025-08-07 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Zimmer Biomet Holdings Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.